Approvals/CIMA-AEMPS/AMLODIPINO/VALSARTAN MAXMIND 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

AMLODIPINO/VALSARTAN MAXMIND 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Maxmind Pharmaceutical S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 37ef156426824886
Drug Cima Aemps Name: AMLODIPINO/VALSARTAN MAXMIND 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85844
Holder Company Name: Maxmind Pharmaceutical S.L.
Marketing Company Name: Maxmind Pharmaceutical S.L.
Holder Company Detail Path: /organization/maxmind-pharmaceutical-sl
Marketing Company Detail Path: /organization/maxmind-pharmaceutical-sl
Authorization Date: 2021-03-15
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 10 mg/160 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Maxmind Pharmaceutical S.L.
Company Detail Path: /organization/maxmind-pharmaceutical-sl

AMLODIPINO BESILATO

13,87 mg

VALSARTAN

160 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 15, 2021

Approval ID

37ef156426824886

Type

Standard